🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
45.14
-2.18 (-4.61%)
Nov 20, 2026, 5:29 PM CET

Hansa Biopharma AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,337701.08405.28732.061,496651.34
Short-Term Investments
-----237.62
Cash & Short-Term Investments
1,337701.08405.28732.061,496888.96
Cash Growth
430.48%72.99%-44.64%-51.07%68.31%-35.47%
Accounts Receivable
68.8253.8726.7878.0342.969.71
Other Receivables
122.8618.2117.4915.7324.2213.53
Receivables
191.6872.0844.2793.7667.1823.24
Inventory
5.996.132.611.510.970.24
Prepaid Expenses
-3.472.843.063.523.34
Other Current Assets
-13.8512.2424.7636.8526.56
Total Current Assets
1,535796.61467.24855.151,605942.34
Property, Plant & Equipment
5.5913.3517.8827.0735.8441.71
Other Intangible Assets
241.2417.4120.4623.1726.0128.76
Long-Term Accounts Receivable
122.57126.25118.19---
Long-Term Deferred Charges
22.24213.15176.88112.6520.85-
Total Assets
1,9261,167800.641,0181,6871,013

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
72.6654.0637.6286.9762.4853.36
Accrued Expenses
89.3794.2397.89116.54100.3278.22
Current Portion of Long-Term Debt
199.58136.87----
Current Portion of Leases
2.348.287.687.57.176.89
Current Income Taxes Payable
2.271.832.711.60.6-
Current Unearned Revenue
486.49-16.3341.4740.4324.96
Other Current Liabilities
94.54115.493.4566.9153.717.79
Total Current Liabilities
947.24410.66255.69320.99264.71171.22
Long-Term Debt
744.63790.531,065844.9762.6-
Long-Term Leases
1.7436.6814.3621.3328.49
Long-Term Unearned Revenue
612.751.61--29.547.02
Long-Term Deferred Tax Liabilities
0.10.260.170.370.410.43
Other Long-Term Liabilities
305.4749.7163.35.35.958.08
Total Liabilities
2,6121,2561,3901,1861,084255.24

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
-685.44101.7667.8155.0355.0346.34
Additional Paid-In Capital
-4,4573,4543,0833,0222,573
Retained Earnings
--4,644-4,110-3,303-2,471-1,860
Treasury Stock
--2.03-2.36-2.36-2.59-1.86
Comprehensive Income & Other
--2.030.94-0.410.010.13
Shareholders' Equity
-685.44-88.99-589.83-167.88602.91757.57
Total Liabilities & Equity
1,9261,167800.641,0181,6871,013

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
948.28938.671,079866.77791.0935.38
Net Cash (Debt)
388.9-237.59-673.73-134.71705.09853.58
Net Cash Growth
-----17.40%-37.81%
Net Cash Per Share
3.82-2.93-10.72-2.5615.7019.19
Filing Date Shares Outstanding
101.99101.7667.8152.6752.4444.47
Total Common Shares Outstanding
101.99101.7667.8152.6752.4444.47
Working Capital
587.61385.95211.56534.161,340771.12
Book Value Per Share
-6.72-0.87-8.70-3.1911.5017.03
Tangible Book Value
-926.67-106.4-610.29-191.05576.9728.81
Tangible Book Value Per Share
-9.09-1.05-9.00-3.6311.0016.39